135 related articles for article (PubMed ID: 12722962)
21. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
Hindmarch ; Shamsi Z
Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
[TBL] [Abstract][Full Text] [Related]
22. Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate.
Theunissen EL; Elvira Jde L; van den Bergh D; Ramaekers JG
J Clin Psychopharmacol; 2009 Oct; 29(5):439-43. PubMed ID: 19745643
[TBL] [Abstract][Full Text] [Related]
23. The effects of antihistamines with varying anticholinergic properties on voluntary and involuntary movement.
Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
Clin Neurophysiol; 2013 Sep; 124(9):1840-5. PubMed ID: 23643576
[TBL] [Abstract][Full Text] [Related]
24. The effects of cimetidine and ranitidine on psychomotor function in healthy volunteers.
Levin A; Barbat JR; Hedges A; Turner P
Curr Med Res Opin; 1984; 9(5):301-3. PubMed ID: 6099262
[TBL] [Abstract][Full Text] [Related]
25. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
[TBL] [Abstract][Full Text] [Related]
26. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.
Gandon JM; Allain H
Br J Clin Pharmacol; 2002 Jul; 54(1):51-8. PubMed ID: 12100225
[TBL] [Abstract][Full Text] [Related]
27. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials.
Huang CZ; Jiang ZH; Wang J; Luo Y; Peng H
BMC Pharmacol Toxicol; 2019 Nov; 20(1):72. PubMed ID: 31783781
[TBL] [Abstract][Full Text] [Related]
28. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
Tashiro M; Horikawa E; Mochizuki H; Sakurada Y; Kato M; Inokuchi T; Ridout F; Hindmarch I; Yanai K
Hum Psychopharmacol; 2005 Oct; 20(7):501-9. PubMed ID: 16086364
[TBL] [Abstract][Full Text] [Related]
29. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.
Theunissen EL; van Kroonenburgh MJ; van Deursen JA; Blom-Coenjaerts C; Ramaekers JG
Psychopharmacology (Berl); 2006 Jul; 187(1):95-102. PubMed ID: 16767419
[TBL] [Abstract][Full Text] [Related]
30. Peripheral H1-blockade effect of fexofenadine.
Simons FE; Simons KJ
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
[TBL] [Abstract][Full Text] [Related]
31. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
33. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
[TBL] [Abstract][Full Text] [Related]
34. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.
Vermeeren A; O'Hanlon JF
J Allergy Clin Immunol; 1998 Mar; 101(3):306-11. PubMed ID: 9525444
[TBL] [Abstract][Full Text] [Related]
35. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
36. The systemic safety of fexofenadine HCl.
Mason J; Reynolds R; Rao N
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
[TBL] [Abstract][Full Text] [Related]
37. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.
Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P
Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096
[TBL] [Abstract][Full Text] [Related]
38. The effects of fexofenadine on reaction time, decision-making, and driver behavior.
Potter PC; Schepers JM; Van Niekerk CH
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):177-81. PubMed ID: 12952112
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
Hindmarch I; Trick L; Ridout F
Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
[TBL] [Abstract][Full Text] [Related]
40. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.
Parrott AC; Wesnes K
Psychopharmacology (Berl); 1987; 92(4):513-9. PubMed ID: 3114803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
